DCPH insider trading

CIK 1654151

Deciphera Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades
401
Last 90 days
0
Buys / sells
1% / 56%
Insiders
16

DCPH insider activity at a glance

FilingIQ tracks 401 insider transactions for DCPH in filings since Oct 2, 2017. The most recent transaction is dated Apr 22, 2024. They were reported by 16 insiders.

Across the full history, 6 open-market purchases and 224 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest DCPH Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to DCPH by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for DCPH?
FilingIQ tracks 401 Form 4 insider transactions for DCPH (Deciphera Pharmaceuticals, Inc.), covering filings from Oct 2, 2017 onwards. 0 of those are dated within the last 90 days.
Are DCPH insiders net buyers or net sellers?
Across the full Form 4 history for DCPH, 6 transactions (1%) were open-market purchases and 224 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DCPH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every DCPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.